Kamran Movassaghi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kamran Movassaghi has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Arpan Patel
Department of Orthopaedic Surgery, Rush University Medical Center, Chicago, IL, USA
2 shared publications - Daniel D. Bohl
Department of Orthopedic Surgery, Rush University Medical Center, Chicago, IL, USA
2 shared publications Adam P. Schiff
Department of Orthopaedic Surgery, Loyola University Health System, Maywood, Illinois
1 shared publicationAlexander J. Idarraga
Department of Orthopaedic Surgery, Rush University Medical Center, Chicago, Illinois
1 shared publication- Andreas Neubauer
Philipps University Marburg
1 shared publication Brandon S. Gettleman
University of South Carolina School of Medicine, Columbia, South Carolina
1 shared publication
Latest Publications
- Open Access
- 21 April 2023
- Published by Elsevier in Arthroplasty Today
- Vol. 21, 101130
Modern Total Knee Arthroplasty Bearing Designs and the Role of the Posterior Cruciate Ligament
- 21 April 2023
- Published by Elsevier in Arthroplasty Today
- Vol. 21, 101130
Open AccessModern Total Knee Arthroplasty Bearing Designs and the Role of the Posterior Cruciate Ligament
- 18 March 2022
- Published by Elsevier in The Journal of Arthroplasty
- Vol. 37 (7) , 1405-1415.e1
Systematic Review and Meta-Analysis of Intrawound Vancomycin in Total Hip and Total Knee Arthroplasty: A Continued Call for a Prospective Randomized Trial
- 18 March 2022
- Published by Elsevier in The Journal of Arthroplasty
- Vol. 37 (7) , 1405-1415.e1
Systematic Review and Meta-Analysis of Intrawound Vancomycin in Total Hip and Total Knee Arthroplasty: A Continued Call for a Prospective Randomized Trial
- Open Access
- 28 February 2022
- Published by Elsevier in Arthroplasty Today
- Vol. 14, 71-75
An Atypical Adverse Local Tissue Reaction After Ceramic-on-Ceramic Primary Total Hip Arthroplasty
- 28 February 2022
- Published by Elsevier in Arthroplasty Today
- Vol. 14, 71-75
Open AccessAn Atypical Adverse Local Tissue Reaction After Ceramic-on-Ceramic Primary Total Hip Arthroplasty
- 25 August 2020
- Published by SAGE Publications in Foot & Ankle Specialist
- Vol. 15 (3) , 236-243
Adverse Events Following Minimally Invasive Achilles Tendon Repair
The rate of wound complications following traditional open Achilles tendon repair is reported at 7.6%. The purpose of this study is to characterize the rate of wound and other early complications following a specific minimally invasive Achilles tendon repair technique, and to identify any factors associated with increased risk. The postoperative courses of 99 patients who underwent minimally invasive Achilles tendon repair by 2 surgeons at separate academic medical centers were retrospectively reviewed. Mean follow-up was 8.1 months (range 3.0-24.6 months). Repair technique was similar in all cases with the exception that 71 procedures used a longitudinal incision and a tourniquet, while 28 procedures used a transverse incision and no tourniquet (surgeon preference). The rates of complications were compared between patients with differing baseline and procedural characteristics. Of the 99 patients included in the study, 2 (2.0%) developed wound complications. There was no statistical difference in the rate of wound complications between patients in the longitudinal incision/tourniquet group and patients in the transverse incision/no tourniquet group (2.8% vs 0%; P = 1.000). Four patients (4.0%) developed sural neuropraxia. One patient developed deep venous thrombosis. There were no cases of rerupture. At final follow-up, all 99 patients had intact Thompson tests and well-healed wounds. The rate of wound complications following minimally invasive Achilles tendon repair is low at 2.0%. Patients should be counseled that although risk for wound complications may be lower with this minimally invasive technique, there are risks for sural neuropraxia and deep suture reaction. Level III, Retrospective study
- 25 August 2020
- Published by SAGE Publications in Foot & Ankle Specialist
- Vol. 15 (3) , 236-243
Adverse Events Following Minimally Invasive Achilles Tendon Repair
The rate of wound complications following traditional open Achilles tendon repair is reported at 7.6%. The purpose of this study is to characterize the rate of wound and other early complications following a specific minimally invasive Achilles tendon repair technique, and to identify any factors associated with increased risk. The postoperative courses of 99 patients who underwent minimally invasive Achilles tendon repair by 2 surgeons at separate academic medical centers were retrospectively reviewed. Mean follow-up was 8.1 months (range 3.0-24.6 months). Repair technique was similar in all cases with the exception that 71 procedures used a longitudinal incision and a tourniquet, while 28 procedures used a transverse incision and no tourniquet (surgeon preference). The rates of complications were compared between patients with differing baseline and procedural characteristics. Of the 99 patients included in the study, 2 (2.0%) developed wound complications. There was no statistical difference in the rate of wound complications between patients in the longitudinal incision/tourniquet group and patients in the transverse incision/no tourniquet group (2.8% vs 0%; P = 1.000). Four patients (4.0%) developed sural neuropraxia. One patient developed deep venous thrombosis. There were no cases of rerupture. At final follow-up, all 99 patients had intact Thompson tests and well-healed wounds. The rate of wound complications following minimally invasive Achilles tendon repair is low at 2.0%. Patients should be counseled that although risk for wound complications may be lower with this minimally invasive technique, there are risks for sural neuropraxia and deep suture reaction. Level III, Retrospective study
- 1 March 2019
- Published by Wolters Kluwer Health in JBJS Reviews
- Vol. 7 (3) , e6
Septic Arthritis of the Native Ankle
» Septic arthritis of the ankle is a serious condition that requires immediate recognition and treatment. Delay may result in permanent destruction of the cartilage and the joint, and the infection may spread to nearby tissues or cause sepsis. »Staphylococcus aureusis the most common causative organism of septic arthritis of the ankle. » Septic arthritis of the ankle typically presents as a tender, warm, and erythematous ankle joint with painful and limited range of motion. » Serum and joint fluid analysis as well as culture and Gram staining should aid in the diagnosis. » Treatment typically includes surgical drainage and antibiotic therapy.
- 1 March 2019
- Published by Wolters Kluwer Health in JBJS Reviews
- Vol. 7 (3) , e6
Septic Arthritis of the Native Ankle
» Septic arthritis of the ankle is a serious condition that requires immediate recognition and treatment. Delay may result in permanent destruction of the cartilage and the joint, and the infection may spread to nearby tissues or cause sepsis. »Staphylococcus aureusis the most common causative organism of septic arthritis of the ankle. » Septic arthritis of the ankle typically presents as a tender, warm, and erythematous ankle joint with painful and limited range of motion. » Serum and joint fluid analysis as well as culture and Gram staining should aid in the diagnosis. » Treatment typically includes surgical drainage and antibiotic therapy.
- 24 October 2003
- Published by Wiley in Transfusion
- Vol. 43 (11) , 1587-1595
Bacterial contamination of ex vivo processed PBPC products under clean room conditions
Patients undergoing high-dose radio- and/or chemotherapy and autologous or allogeneic PBPC transplantation are at high risk for infections owing to profound immunosuppression. In this study, the rate of microbial contamination of ex vivo processed PBPC products was analyzed, comparing preparation under clean room conditions to standard laboratory conditions. After implementation of good manufacturing practice conditions in the two participating institutions, the microbial contamination rate of 366 PBPC harvests from 198 patients was determined under certified clean room conditions (Group A) from 2000 until 2002. To investigate influence of improved environmental conditions along with other parameters, this set of samples was compared with a historical control set of 1413 PBPC products, which have been processed ex vivo under a clean bench in a regular laboratory room and were harvested from 626 patients (Group B) from 1989 until 2000. In Group B microbial contamination was found in 74 PBPC products (5.2%) from 57 patients. In Group A microbial growth was detected in 3 leukapheresis products (0.8%) from 3 patients. After exclusion of PBPC products, which were probably contaminated before manipulation, statistical analysis showed a significant difference (chi2= 10.339; p < 0.001). These data suggest an impact of clean room conditions on the bacterial contamination rate of PBPC products. To identify confounding variables, variables like technique of leukapheresis, culture methodology, and microbial colonization of central venous catheters were taken into account. Further variables might be identified in following studies.
- 24 October 2003
- Published by Wiley in Transfusion
- Vol. 43 (11) , 1587-1595
Bacterial contamination of ex vivo processed PBPC products under clean room conditions
Patients undergoing high-dose radio- and/or chemotherapy and autologous or allogeneic PBPC transplantation are at high risk for infections owing to profound immunosuppression. In this study, the rate of microbial contamination of ex vivo processed PBPC products was analyzed, comparing preparation under clean room conditions to standard laboratory conditions. After implementation of good manufacturing practice conditions in the two participating institutions, the microbial contamination rate of 366 PBPC harvests from 198 patients was determined under certified clean room conditions (Group A) from 2000 until 2002. To investigate influence of improved environmental conditions along with other parameters, this set of samples was compared with a historical control set of 1413 PBPC products, which have been processed ex vivo under a clean bench in a regular laboratory room and were harvested from 626 patients (Group B) from 1989 until 2000. In Group B microbial contamination was found in 74 PBPC products (5.2%) from 57 patients. In Group A microbial growth was detected in 3 leukapheresis products (0.8%) from 3 patients. After exclusion of PBPC products, which were probably contaminated before manipulation, statistical analysis showed a significant difference (chi2= 10.339; p < 0.001). These data suggest an impact of clean room conditions on the bacterial contamination rate of PBPC products. To identify confounding variables, variables like technique of leukapheresis, culture methodology, and microbial colonization of central venous catheters were taken into account. Further variables might be identified in following studies.